Layer-by-Layer-Assembled Multilayer Films for Transcutaneous Drug and Vaccine Delivery

We describe protein- and oligonucleotide-loaded layer-by-layer (LbL)-assembled multilayer films incorporating a hydrolytically degradable polymer for transcutaneous drug or vaccine delivery. Films were constructed based on electrostatic interactions between a cationic poly(β-amino ester) (denoted Poly-1) with a model protein antigen, ovalbumin (ova), and/or immunostimulatory CpG (cytosine−phosphate diester−guanine-rich) DNA oligonucleotide adjuvant molecules. Linear growth of nanoscale Poly-1/ova bilayers was observed. Dried ova protein-loaded films rapidly deconstructed when rehydrated in saline solutions, releasing ova as nonaggregated/nondegraded protein, suggesting that the structure of biomolecules integrated into these multilayer films is preserved during release. Using confocal fluorescence microscopy and an in vivo murine ear skin model, we demonstrated delivery of ova from LbL films into barrier-disrupted skin, uptake of the protein by skin-resident antigen-presenting cells (Langerhans cells), and transport of the antigen to the skin-draining lymph nodes. Dual incorporation of ova and CpG oligonucleotides into the nanolayers of LbL films enabled dual release of the antigen and adjuvant with distinct kinetics for each component; ova was rapidly released, while CpG was released in a relatively sustained manner. Applied as skin patches, these films delivered ova and CpG to Langerhans cells in the skin. To our knowledge, this is the first demonstration of LbL films applied for the delivery of biomolecules into skin. This approach provides a new route for storage of vaccines and other immunotherapeutics in a solid-state thin film for subsequent delivery into the immunologically rich milieu of the skin.Massachusetts Institute of Technology. Institute for Soldier NanotechnologiesSingapore. Agency for Science, Technology and Researc

The Grounded Model of Communication Savoring: Theory Development and Age Cohort Study

Savoring contributes to human flourishing by enabling individuals to optimize, enhance, and prolong pleasurable moments. One unique dimension of savoring, communication savoring, refers to the practice of mindfully attending to and elevating pleasurable or meaningful moments that are experienced in language and social interaction. The grounded model of communication savoring identified the types and phenomenological experiences of communication savoring. The purpose of this study is to continue grounded theoretical development of the communication savoring model by adding new cases to build and refine the model and by applying the model to a novel setting. Using a priori and emergent coding, we analyzed 268 communication savoring narratives from 107 emerging adults and 161 mature/older adults. Our findings demonstrate high fidelity across groups and suggest a refinement to one communication savoring type (i.e., extraordinary communication). Our novel application of the model also revealed generational similarities within the contexts for communication savoring (e.g., people and events) and generational differences regarding the valence (i.e., savoring the bittersweet) and target of communication savoring (i.e., giving vs. receiving). Our paper advances qualitative theory-building in positive social science and offers new insight into age differences in communication savoring

Approach to hematopoietic cell transplant candidates with respiratory viral detection

The management of respiratory viruses prior to hematopoietic cell transplant (HCT) can be controversial and requires special consideration of host factors, transplant parameters, and the specific respiratory virus (RV). In the setting of adenovirus (ADV), human metapneumovirus (HMPV), influenza, parainfluenza virus (PIV), and respiratory syncytial virus (RSV) detection prior to hematopoietic cell transplant (HCT), clinical practice guidelines recommend transplant delay when possible; however, there is much more ambiguity when other respiratory viruses, such as seasonal coronaviruses (CoVs), human rhinovirus (HRV), and SARS-CoV-2, are detected. Our aims for this review include detailing clinical practical guidelines and reviewing current literature on pre-transplant respiratory viral infections (RVIs), including antiviral therapies and prevention strategies, when available. We will center our discussion on three representative clinical scenarios, with the goal of providing practical guidance to clinicians

Literature and Music Reviews

Panel Chair: Lubna Javeed, Collin Colleg

Identification of antiviral roles for the exon-junction complex and nonsense-mediated decay in flaviviral infection.

West Nile virus (WNV) is an emerging mosquito-borne flavivirus, related to dengue virus and Zika virus. To gain insight into host pathways involved in WNV infection, we performed a systematic affinity-tag purification mass spectrometry (APMS) study to identify 259 WNV-interacting human proteins. RNA interference screening revealed 26 genes that both interact with WNV proteins and influence WNV infection. We found that WNV, dengue and Zika virus capsids interact with a conserved subset of proteins that impact infection. These include the exon-junction complex (EJC) recycling factor PYM1, which is antiviral against all three viruses. The EJC has roles in nonsense-mediated decay (NMD), and we found that both the EJC and NMD are antiviral and the EJC protein RBM8A directly binds WNV RNA. To counteract this, flavivirus infection inhibits NMD and the capsid-PYM1 interaction interferes with EJC protein function and localization. Depletion of PYM1 attenuates RBM8A binding to viral RNA, suggesting that WNV sequesters PYM1 to protect viral RNA from decay. Together, these data suggest a complex interplay between the virus and host in regulating NMD and the EJC

Reintegrating Biology through the Nexus of Energy, Information, and Matter

Information, energy, and matter are fundamental properties of all levels of biological organization, and life emerges from the continuous flux of matter, energy, and information. This perspective piece defines and explains each of the three pillars of this nexus. We propose that a quantitative characterization of the complex interconversions between matter, energy, and information that compose this nexus will help us derive biological insights that connect phenomena across different levels of biological organization. We articulate examples from multiple biological scales that highlight how this nexus approach leads to a more complete understanding of the biological system. Metrics of energy, information, and matter can provide a common currency that helps link phenomena across levels of biological organization. The propagation of energy and information through levels of biological organization can result in emergent properties and system-wide changes that impact other hierarchical levels. Deeper consideration of measured imbalances in energy, information, and matter can help researchers identify key factors that influence system function at one scale, highlighting avenues to link phenomena across levels of biological organization and develop predictive models of biological systems

Investigations of Optical Coherence Properties in an Erbium-doped Silicate Fiber for Quantum State Storage

We studied optical coherence properties of the 1.53 $\mu$m telecommunication transition in an Er$^{3+}$-doped silicate optical fiber through spectral holeburning and photon echoes. We find decoherence times of up to 3.8 $\mu$s at a magnetic field of 2.2 Tesla and a temperature of 150 mK. A strong magnetic-field dependent optical dephasing was observed and is believed to arise from an interaction between the electronic Er$^{3+}$ spin and the magnetic moment of tunneling modes in the glass. Furthermore, we observed fine-structure in the Erbium holeburning spectrum originating from superhyperfine interaction with $^{27}$Al host nuclei. Our results show that Er$^{3+}$-doped silicate fibers are promising material candidates for quantum state storage

Controlled polymerisation and purification of branched poly(lactic acid) surfactants in supercritical carbon dioxide

Product degradability, sustainability and low-toxicity are driving demand for the synthesis of biobased polymers and surfactants. Here we report the synthesis of novel surface active polymers using cyclic esters (D,L-lactide) and temperature sensitive polyols (D-sorbitol) as renewable building blocks. We highlight the modification of chain length and degree of branching to provide a route to tailoring the properties and application performance of these new compounds. High processing temperatures (≥180 °C) and harsh post-reaction treatments are often needed to remove residual monomer and catalysts and these can become barriers to creating materials based on renewable resources. Here we exploit supercritical carbon dioxide (scCO2) as a green solvent to overcome these challenges; significantly reducing reaction temperatures, targeting controlled molecular weights with narrow dispersities and reducing sideproduct formation. Additionally in the same pot, we can use supercritical extraction to purify the compounds and to efficiently remove unreacted reagents, which could be recovered and recycled. We believe that our approach to the production and purification of these novel branched poly(lactides) is a significant step towards the development of the next generation of biopolymers and green surfactants, combining both the use of bio-sourced raw materials and the potential to use sustainable, low energy processes and techniques

Association Between Chronic Hepatitis C Virus Infection and Myocardial Infarction Among People Living With HIV in the United States.

Hepatitis C virus (HCV) infection is common among people living with human immunodeficiency virus (PLWH). Extrahepatic manifestations of HCV, including myocardial infarction (MI), are a topic of active research. MI is classified into types, predominantly atheroembolic type 1 MI (T1MI) and supply-demand mismatch type 2 MI (T2MI). We examined the association between HCV and MI among patients in the Centers for AIDS Research (CFAR) Network of Integrated Clinical Systems, a US multicenter clinical cohort of PLWH. MIs were centrally adjudicated and categorized by type using the Third Universal Definition of Myocardial Infarction. We estimated the association between chronic HCV (RNA+) and time to MI while adjusting for demographic characteristics, cardiovascular risk factors, clinical characteristics, and history of injecting drug use. Among 23,407 PLWH aged ≥18 years, there were 336 T1MIs and 330 T2MIs during a median of 4.7 years of follow-up between 1998 and 2016. HCV was associated with a 46% greater risk of T2MI (adjusted hazard ratio (aHR) = 1.46, 95% confidence interval (CI): 1.09, 1.97) but not T1MI (aHR = 0.87, 95% CI: 0.58, 1.29). In an exploratory cause-specific analysis of T2MI, HCV was associated with a 2-fold greater risk of T2MI attributed to sepsis (aHR = 2.01, 95% CI: 1.25, 3.24). Extrahepatic manifestations of HCV in this high-risk population are an important area for continued research